TK
Publicaties op Oncologisch.com
Pharmacodynamics of Camizestrant Behandeling in Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal...
Eerstelijns Camizestrant for Emerging ESR1-Mutated Gevorderd Breast Cancer.
Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positi...
Farmacodynamische vergelijking van CDK4/6-remmers bij mammacarcinoom: window-of-opportunity